Theratechnologies Inc.

Total Valuation

Theratechnologies Inc. carries a market capitalization of 155.87M, placing it among publicly traded companies globally. Its enterprise value stands at 164.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Theratechnologies Inc. currently has 45.98M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 1.55, and the price-to-book ratio stands at -2.28.

Enterprise Valuation

On an enterprise value basis, Theratechnologies Inc. trades at an EV/EBITDA multiple of 18.14 and an EV/FCF ratio of 6.10. The EV/Sales ratio of 1.95 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.10 provides insight into valuation relative to core operating earnings.

Financial Position

Theratechnologies Inc. maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -156.22, indicating conservative leverage, while an interest coverage ratio of 1.24 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Theratechnologies Inc. has paid 2.33M in income taxes, reflecting an effective tax rate of 92.06.

Stock Price Statistics

Theratechnologies Inc.'s stock has gained approximately 175.60976% over the past 52 weeks. The 50-day moving average sits at 3.26, while the 200-day moving average is 2.45.

Income Statement

Over the trailing twelve months, Theratechnologies Inc. generated 84.38M in revenue and converted that into -9.16M in net income, yielding earnings per share of -0.18. EBITDA reached 9.07M, while operating income came in at 7.12M.

Balance Sheet

Theratechnologies Inc. holds 9.92M in cash and equivalents against 43.62M in total debt, resulting in a net debt position of 33.28M. Total book value stands at -57.27M, with working capital of -6.15M providing operational flexibility.

Cash Flow

Theratechnologies Inc. produced 7.04M in operating cash flow over the past twelve months. After subtracting -10.11M in capital expenditures, free cash flow totaled -3.08M - equivalent to -0.06 per share.

Margins

Theratechnologies Inc. operates with a gross margin of 77.72, reflecting its pricing power and cost economics. The operating margin of 8.44 and net profit margin of -10.85 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Theratechnologies Inc.'s most recent stock split took place on July 31, 2023 with a 4:1 split ratio.

Scores

Theratechnologies Inc. posts an Altman Z-Score of -13.26, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.